{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:10:04Z","timestamp":1756368604234,"version":"3.44.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00108-025-01960-y","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T10:00:05Z","timestamp":1753783205000},"page":"896-902","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Malignome und Transplantation","Malignant neoplasms and transplantation"],"prefix":"10.1007","volume":"66","author":[{"given":"Sibylle","family":"von Vietinghoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Manekeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Brossart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Kalff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian P.","family":"Strassburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"1960_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2215\/CJN.14570920","volume":"17","author":"D Al-Adra","year":"2022","unstructured":"Al-Adra\u00a0D, Al-Qaoud\u00a0T, Fowler\u00a0K, Wong\u00a0G (2022) De Novo Malignancies after Kidney Transplantation. CJASN 17:434\u2013443. https:\/\/doi.org\/10.2215\/CJN.14570920","journal-title":"CJASN"},{"key":"1960_CR2","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1055\/a-2255-7246","volume":"62","author":"T Berg","year":"2024","unstructured":"Berg\u00a0T, Aehling\u00a0NF, Bruns\u00a0T et\u00a0al (2024) S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft f\u00fcr Allgemein- und Viszeralchirurgie (DGAV): Version\u00a01.0 \u2013 Dezember 2023 \u2013 AWMF-Registernummer: 021\u2013029. Z\u00a0Gastroenterol 62:1397\u20131573. https:\/\/doi.org\/10.1055\/a-2255-7246","journal-title":"Z Gastroenterol"},{"key":"1960_CR3","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.34067\/KID.0000000000000545","volume":"5","author":"M Bigotte Vieira","year":"2024","unstructured":"Bigotte Vieira\u00a0M, Arai\u00a0H, Nicolau\u00a0C, Murakami\u00a0N (2024) Cancer Screening and Cancer Treatment in Kidney Transplant Recipients. Kidney 5:1569\u20131583. https:\/\/doi.org\/10.34067\/KID.0000000000000545","journal-title":"Kidney"},{"key":"1960_CR4","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1161\/HYPERTENSIONAHA.123.21274","volume":"80","author":"MG Birck","year":"2023","unstructured":"Birck\u00a0MG, Moura\u00a0CS, Machado\u00a0MAA et\u00a0al (2023) Skin Cancer and Hydrochlorothiazide: Novel Population-Based Analyses Considering Personal Risk Factors Including Race\/Ethnicity. Hypertension 80:2218\u20132225. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.21274","journal-title":"Hypertension"},{"key":"1960_CR5","doi-asserted-by":"publisher","first-page":"103736","DOI":"10.1016\/j.esmoop.2024.103736","volume":"9","author":"H Bolek","year":"2024","unstructured":"Bolek\u00a0H, Yazgan\u00a0SC, Yeked\u00fcz\u00a0E et\u00a0al (2024) Androgen receptor pathway inhibitors and drug\u2013drug interactions in prostate cancer. Esmo Open 9:103736. https:\/\/doi.org\/10.1016\/j.esmoop.2024.103736","journal-title":"Esmo Open"},{"key":"1960_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/TP.0000000000003136","volume":"S11","author":"SJ Chadban","year":"2020","unstructured":"Chadban\u00a0SJ, Ahn\u00a0C, Axelrod\u00a0DA et\u00a0al (2020) KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Transplantation S11:104\u2013S103. https:\/\/doi.org\/10.1097\/TP.0000000000003136","journal-title":"Transplantation"},{"key":"1960_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf004","author":"M Charkviani","year":"2025","unstructured":"Charkviani\u00a0M, Brochero\u00a0MJV, Mohan\u00a0A et\u00a0al (2025) Incidence of Acute Kidney Injury in Relapsed and Refractory Multiple Myeloma treated with Teclistamab versus CAR T\u2011cells. Nephrol Dial Transplantation:gfaf004. https:\/\/doi.org\/10.1093\/ndt\/gfaf004","journal-title":"Nephrol Dial Transplantation:gfaf004"},{"key":"1960_CR8","unstructured":"Collaborative Transplant Study Group (2023) Transplant Newsletter. https:\/\/www.ctstransplant.org\/public\/newsletters.shtml"},{"key":"1960_CR9","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2024.0193","author":"S Delecluse","year":"2024","unstructured":"Delecluse\u00a0S, Harder\u00a0F, Keller\u00a0F et\u00a0al (2024) Onconephrology: The Significance of Renal Function for the Development, Diagnosis, and Treatment of Cancer. Dtsch Arztebl Int:arzteblm20240193. https:\/\/doi.org\/10.3238\/arztebl.m2024.0193","journal-title":"Dtsch Arztebl Int:arzteblm20240193"},{"key":"1960_CR10","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1097\/TP.0000000000003773","volume":"106","author":"A Dharia","year":"2022","unstructured":"Dharia\u00a0A, Boulet\u00a0J, Sridhar\u00a0VS, Kitchlu\u00a0A (2022) Cancer Screening in Solid Organ Transplant Recipients: A\u00a0Focus on Screening Liver, Lung, and Kidney Recipients for Cancers Related to the Transplanted Organ. Transplantation 106:e64\u2013e65. https:\/\/doi.org\/10.1097\/TP.0000000000003773","journal-title":"Transplantation"},{"key":"1960_CR11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jaad.2021.07.065","volume":"86","author":"JR Dusendang","year":"2022","unstructured":"Dusendang\u00a0JR, Carlson\u00a0E, Lee\u00a0DS et\u00a0al (2022) Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication. J\u00a0Am Acad Dermatol 86:598\u2013606. https:\/\/doi.org\/10.1016\/j.jaad.2021.07.065","journal-title":"J Am Acad Dermatol"},{"key":"1960_CR12","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.2217\/fon-2020-0403","volume":"16","author":"PJ Goebell","year":"2020","unstructured":"Goebell\u00a0PJ, Ivanyi\u00a0P, Bedke\u00a0J et\u00a0al (2020) Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma. Future Oncol 16:2307\u20132328. https:\/\/doi.org\/10.2217\/fon-2020-0403","journal-title":"Future Oncol"},{"key":"1960_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00108-015-3805-x","volume":"57","author":"J Gottlieb","year":"2016","unstructured":"Gottlieb\u00a0J, Gwinner\u00a0W, Strassburg\u00a0CP (2016) Allocation systems in transplantation medicine: Advantages and disadvantages. Internist (berl) 57:15\u201324. https:\/\/doi.org\/10.1007\/s00108-015-3805-x","journal-title":"Internist (berl)"},{"key":"1960_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.kint.2024.09.017","volume":"107","author":"SM Herrmann","year":"2025","unstructured":"Herrmann\u00a0SM, Abudayyeh\u00a0A, Gupta\u00a0S et\u00a0al (2025) Diagnosis and management of immune checkpoint inhibitor\u2013associated nephrotoxicity: a\u00a0position statement from the American Society of Onco-nephrology. Kidney Int 107:21\u201332. https:\/\/doi.org\/10.1016\/j.kint.2024.09.017","journal-title":"Kidney Int"},{"key":"1960_CR15","doi-asserted-by":"publisher","first-page":"2216116","DOI":"10.1080\/21645515.2023.2216116","volume":"19","author":"K Kline","year":"2023","unstructured":"Kline\u00a0K, Chen\u00a0W, Kallen\u00a0ME et\u00a0al (2023) Chimeric antigen receptor (CAR) T\u00a0cells for the treatment of a\u00a0kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD). Hum Vaccines Immunother 19:2216116. https:\/\/doi.org\/10.1080\/21645515.2023.2216116","journal-title":"Hum Vaccines Immunother"},{"key":"1960_CR16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/ajt.16367","volume":"21","author":"S Krishnamoorthy","year":"2021","unstructured":"Krishnamoorthy\u00a0S, Ghobadi\u00a0A, Santos\u00a0RD et\u00a0al (2021) CAR\u2011T therapy in solid organ transplant recipients with treatment refractory posttransplant lymphoproliferative disorder. Am J Transplant 21:809\u2013814. https:\/\/doi.org\/10.1111\/ajt.16367","journal-title":"Am J Transplant"},{"key":"1960_CR17","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/TP.0000000000001769","volume":"101","author":"KL Lentine","year":"2017","unstructured":"Lentine\u00a0KL, Kasiske\u00a0BL, Levey\u00a0AS et\u00a0al (2017) KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation 101:S7\u2013S105. https:\/\/doi.org\/10.1097\/TP.0000000000001769","journal-title":"Transplantation"},{"issue":"2","key":"1960_CR18","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1002\/lt.22365","volume":"17","author":"V Mazzaferro","year":"2011","unstructured":"Mazzaferro\u00a0V, Bhoori\u00a0S, Sposito\u00a0C et\u00a0al (2011) Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15\u00a0years of experience. Liver Transpl 17(2):S44\u201357. https:\/\/doi.org\/10.1002\/lt.22365","journal-title":"Liver Transpl"},{"key":"1960_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11560-021-00561-8","volume":"17","author":"C Morath","year":"2022","unstructured":"Morath\u00a0C, Zeier\u00a0M (2022) KDIGO-Leitlinie zu Evaluation und Management von Nierentransplantationskandidaten: Kommentierte deutsche \u00dcbersetzung der Zusammenfassung. Nephrologe 17:44\u201350. https:\/\/doi.org\/10.1007\/s11560-021-00561-8","journal-title":"Nephrologe"},{"key":"1960_CR20","doi-asserted-by":"publisher","first-page":"sfae126","DOI":"10.1093\/ckj\/sfae126","volume":"17","author":"R Rahamimov","year":"2024","unstructured":"Rahamimov\u00a0R, Telem\u00a0S, Davidovichi\u00a0B et\u00a0al (2024) The association between hydrochlorothiazide use and non-melanoma skin cancer in kidney transplant recipients. Clin Kidney\u00a0J 17:sfae126. https:\/\/doi.org\/10.1093\/ckj\/sfae126","journal-title":"Clin Kidney J"},{"key":"1960_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ejca.2022.08.010","volume":"175","author":"A R\u00fcnger","year":"2022","unstructured":"R\u00fcnger\u00a0A, Schadendorf\u00a0D, Hauschild\u00a0A, Gebhardt\u00a0C (2022) Immune checkpoint blockade for organ-transplant recipients with cancer: A\u00a0review. Eur J Cancer 175:326\u2013335. https:\/\/doi.org\/10.1016\/j.ejca.2022.08.010","journal-title":"Eur J Cancer"},{"key":"1960_CR22","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/ndt\/gfac239","volume":"38","author":"K Serkies","year":"2023","unstructured":"Serkies\u00a0K, D\u0119bska-\u015alizie\u0144\u00a0A, Kowalczyk\u00a0A et\u00a0al (2023) Malignancies in adult kidney transplant candidates and recipients: current status. Nephrol Dial Transplant 38:1591\u20131602. https:\/\/doi.org\/10.1093\/ndt\/gfac239","journal-title":"Nephrol Dial Transplant"},{"key":"1960_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000446385","volume":"32","author":"CP Strassburg","year":"2016","unstructured":"Strassburg\u00a0CP (2016) HCC-Associated Liver Transplantation\u2014Where Are the Limits and What Are the New Regulations? Visc Med 32:263\u2013271. https:\/\/doi.org\/10.1159\/000446385","journal-title":"Visc Med"},{"key":"1960_CR24","doi-asserted-by":"publisher","first-page":"sfae061","DOI":"10.1093\/ckj\/sfae061","volume":"17","author":"T Van Meerhaeghe","year":"2024","unstructured":"Van Meerhaeghe\u00a0T, Murakami\u00a0N, Le Moine\u00a0A et\u00a0al (2024) Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients. Clin Kidney\u00a0J 17:sfae61. https:\/\/doi.org\/10.1093\/ckj\/sfae061","journal-title":"Clin Kidney J"},{"key":"1960_CR25","doi-asserted-by":"publisher","first-page":"151500","DOI":"10.1016\/j.semnephrol.2024.151500","volume":"44","author":"K Venkataraman","year":"2024","unstructured":"Venkataraman\u00a0K, Salehi\u00a0T, Carroll\u00a0RP (2024) Immune Checkpoint Inhibitors in Recipients of Renal Allografts. Semin Nephrol 44:151500. https:\/\/doi.org\/10.1016\/j.semnephrol.2024.151500","journal-title":"Semin Nephrol"},{"key":"1960_CR26","unstructured":"Vorstand der Bundes\u00e4rztekammer (2024) Richtlinie gem. \u00a7\u00a016 Abs.\u00a01 S.\u00a01 Nrn.\u00a02 und\u00a05 TPG f\u00fcr die Wartelistenf\u00fchrung und Organvermittlung zur Lebertransplantation."},{"key":"1960_CR27","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1097\/TP.0000000000005056","volume":"108","author":"KD Watt","year":"2024","unstructured":"Watt\u00a0KD, Rolak\u00a0S, Foley\u00a0DP et\u00a0al (2024) Cancer Surveillance in Solid Organ Transplant Recipients With a\u00a0Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion. Transplantation 108:2336\u20132350. https:\/\/doi.org\/10.1097\/TP.0000000000005056","journal-title":"Transplantation"},{"key":"1960_CR28","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/cam4.487","volume":"4","author":"EL Yanik","year":"2015","unstructured":"Yanik\u00a0EL, Siddiqui\u00a0K, Engels\u00a0EA (2015) Sirolimus effects on cancer incidence after kidney transplantation: a\u00a0meta-analysis. Cancer Med 4:1448\u20131459. https:\/\/doi.org\/10.1002\/cam4.487","journal-title":"Cancer Med"},{"key":"1960_CR29","unstructured":"(2018) UK Guidelines for Living Donor Kidney Transplantation. https:\/\/bts.org.uk\/guidelines-standards\/"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01960-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-025-01960-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01960-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:31:10Z","timestamp":1756366270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-025-01960-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1960"],"URL":"https:\/\/doi.org\/10.1007\/s00108-025-01960-y","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"type":"print","value":"2731-7080"},{"type":"electronic","value":"2731-7099"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"2 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0von Vietinghoff, S.\u00a0Manekeller, G.\u00a0Fechner, P.\u00a0Brossart, J.\u00a0Kalff, M.\u00a0Ritter und C.P.\u00a0Strassburg geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}